Last reviewed · How we verify
Hepatitis B vaccine, experimental formulation — Competitive Intelligence Brief
phase 2
Biologic
Live · refreshed every 30 min
Target snapshot
Hepatitis B vaccine, experimental formulation (Hepatitis B vaccine, experimental formulation) — GlaxoSmithKline.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Hepatitis B vaccine, experimental formulation TARGET | Hepatitis B vaccine, experimental formulation | GlaxoSmithKline | phase 2 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Hepatitis B vaccine, experimental formulation CI watch — RSS
- Hepatitis B vaccine, experimental formulation CI watch — Atom
- Hepatitis B vaccine, experimental formulation CI watch — JSON
- Hepatitis B vaccine, experimental formulation alone — RSS
Cite this brief
Drug Landscape (2026). Hepatitis B vaccine, experimental formulation — Competitive Intelligence Brief. https://druglandscape.com/ci/hepatitis-b-vaccine-experimental-formulation. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab